Vor Biopharma VOR Stock
Vor Biopharma Price Chart
Vor Biopharma VOR Financial and Trading Overview
| Vor Biopharma stock price | 0.72 USD |
| Previous Close | 5.1 USD |
| Open | 5.15 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 4.84 - 5.33 USD |
| 52 Week Range | 3.48 - 7.57 USD |
| Volume | 173.07K USD |
| Avg. Volume | 123.65K USD |
| Market Cap | 325.41M USD |
| Beta (5Y Monthly) | -0.6875 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.17 USD |
VOR Valuation Measures
| Enterprise Value | 169.73M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.627027 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.4132016 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.73 |
Trading Information
Vor Biopharma Stock Price History
| Beta (5Y Monthly) | -0.6875 |
| 52-Week Change | 2.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.57 USD |
| 52 Week Low | 3.48 USD |
| 50-Day Moving Average | 4.64 USD |
| 200-Day Moving Average | 5.03 USD |
VOR Share Statistics
| Avg. Volume (3 month) | 123.65K USD |
| Avg. Daily Volume (10-Days) | 135.34K USD |
| Shares Outstanding | 66.96M |
| Float | 27.57M |
| Short Ratio | 27.23 |
| % Held by Insiders | 0.90% |
| % Held by Institutions | 90.28% |
| Shares Short | 2.54M |
| Short % of Float | 8.64% |
| Short % of Shares Outstanding | 3.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.67% |
| Return on Equity (ttm) | -46.054% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -98104000 USD |
| Net Income Avi to Common (ttm) | -97790000 USD |
| Diluted EPS (ttm) | -2.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 210.2M USD |
| Total Cash Per Share (mrq) | 3.14 USD |
| Total Debt (mrq) | 38.45M USD |
| Total Debt/Equity (mrq) | 16.7 USD |
| Current Ratio (mrq) | 17.243 |
| Book Value Per Share (mrq) | 3.439 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -86508000 USD |
| Levered Free Cash Flow (ttm) | -53752000 USD |
Profile of Vor Biopharma
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 100 Cambridgepark Drive |
| ZIP | 02140 |
| Phone | 617 655 6580 |
| Website | https://www.vorbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 133 |
Vor Biopharma Inc., a clinical-stage company, engages in the development of engineered hematopoietic stem cell (eHSC) therapies for cancer patients. The company is developing lead product, tremtelectogene empogeditemcel (trem-cel), formerly VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. It also offers Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, currently under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system, currently under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system, made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, currently under preclinical studies for the treatment of AML. Vor Biopharma Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Q&A For Vor Biopharma Stock
What is a current VOR stock price?
Vor Biopharma VOR stock price today per share is 0.72 USD.
How to purchase Vor Biopharma stock?
You can buy VOR shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vor Biopharma?
The stock symbol or ticker of Vor Biopharma is VOR.
Which industry does the Vor Biopharma company belong to?
The Vor Biopharma industry is Biotechnology.
How many shares does Vor Biopharma have in circulation?
The max supply of Vor Biopharma shares is 126.14M.
What is Vor Biopharma Price to Earnings Ratio (PE Ratio)?
Vor Biopharma PE Ratio is now.
What was Vor Biopharma earnings per share over the trailing 12 months (TTM)?
Vor Biopharma EPS is -1.7 USD over the trailing 12 months.
Which sector does the Vor Biopharma company belong to?
The Vor Biopharma sector is Healthcare.
Vor Biopharma VOR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
- {{ link.label }} {{link}}